Pfizer's mRNA flu shot outperforms standard flu vaccine in late-stage trial

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...
Fierce Biotech

Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...
Independent Journal Review

New Studies Probe COVID Vaccine Links to Respiratory Illness and Kidney Risks — Experts Urge Caution

Two major studies published this month are raising new questions about potential health risks associated with the COVID-19 ...

Health chiefs accused of a 'cover up' after failing to reveal data that may link Covid jabs to excess deaths

Last year, a cross-party group of 21 MPs and peers expressed alarm about 'growing public and professional concerns' over the ...